{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_names_stdName in Standardized Name (approximate match)
Status:
US Approved Rx
(2005)
First approved in 1997
Source:
BLA103647
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2005)
First approved in 1997
Source:
BLA103647
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2000)
First approved in 1993
Source:
BLA103935
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2001)
First approved in 1989
Source:
BLA103239
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2017)
First approved in 1986
Source:
BLA101066
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2001)
First approved in 1977
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2016)
Source:
NDA207648
(2016)
Source URL:
First approved in 1975
Source:
INTRALIPID 10% by FRESENIUS
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1971)
First approved in 1971
Source:
BLA101069
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:pritebegene zepadenovec [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:elzocabtagene autoleucel [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE